Gold Falls 1%; Charter Communications Shares Fall After Q3 Results
U.S. stocks gained Friday, led by Nasdaq +1.5%, as jobs beat forecasts. Gogo and JFrog surged, while DraftKings and Biodesix plunged.
Crypto · News reference
Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market Today
The 10-year Treasury yield hit a 19-month high and crude jumped above $88 as traders lifted Fed rate-hike odds to 68%, cracking high-multiple software stocks.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
ADMAPOAXONBGBTCUSDBXCASYCDNSCICIENCNCCOINCRWDCSXCTVACVSDDOGDEDELLDGDIADLTRELVFDNFTNTGDXHUMHWMIBBIBKRIWMJETSKRLITEMDTMOOMOSMRNANOWODFLORCLPANWQQQSNPSVOOXLBXLEXLIXLKXLPXLUXLVXLY
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
12 Industrials Stocks Moving In Friday's Intraday Session
Gainers Tianci International (NASDAQ:CIIT) stock increased by 44.5% to $2.24 during Friday's regular session. The company's market cap stands at $1.8 million. As per the news, the Q4 earnings report came out
Cigna Delivers Strong Q3, Accelerate To One Program Targets $3B Savings By 2030
Cigna shares fell after Q3 results; analysts remain bullish, citing raised guidance, 2027 growth, and strong demand.
BAWAG Group Receives ECB Approval for Permanent TSB Acquisition
BAWAG Group AG has secured European Central Bank (ECB) approval for its planned acquisition of Permanent TSB Group Holdings plc, marking a significant regulatory milestone in the transaction process.
Jobs Report Boosts December Fed Rate Hike Bets
Capitulation Criteria Please click here for an enlarged chart of Direxion Daily Semiconductor Bull 3X ETF (NYSE:SOXL). Note the following: Semiconductors reflect the AI trade, and SOXL is the momo crowd’s
Moderna Stuns Wall Street With Surprise Profit, Raises Outlook
Moderna (MRNA) jumps as Q3 earnings swing to a surprise profit of $0.38/share on strong global vaccine sales and cost cuts.